|
CIR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.89130000052928E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51250000000047E-05 |
| Normal-vs-Stage2 |
2.041800E-02 |
| Normal-vs-Stage3 |
2.21069999999379E-05 |
| Normal-vs-Stage4 |
4.354500E-04 |
| Stage1-vs-Stage2 |
8.946600E-01 |
| Stage1-vs-Stage3 |
7.570000E-01 |
| Stage1-vs-Stage4 |
4.975200E-01 |
| Stage2-vs-Stage3 |
9.642800E-01 |
| Stage2-vs-Stage4 |
6.382600E-01 |
| Stage3-vs-Stage4 |
3.595600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.06699999525529E-08 |
| Normal-vs-AfricanAmerican |
1.182190E-01 |
| Normal-vs-Asian |
6.385000E-01 |
| Caucasian-vs-AfricanAmerican |
1.214150E-01 |
| Caucasian-vs-Asian |
4.490100E-02 |
| AfricanAmerican-vs-Asian |
4.902600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75609999999438E-05 |
| Normal-vs-Female |
6.42189999955356E-07 |
| Male-vs-Female |
2.425800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.431500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.41649999969063E-07 |
| Normal-vs-Age(61-80Yrs) |
2.31609999999938E-05 |
| Normal-vs-Age(81-100Yrs) |
1.466610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.168400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.943600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.673000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.074600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.744600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.565000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.813610E-04 |
| Normal-vs-Grade 2 |
2.86289999484879E-08 |
| Normal-vs-Grade 3 |
1.915270E-03 |
| Normal-vs-Grade 4 |
1.790090E-04 |
| Grade 1-vs-Grade 2 |
6.656000E-01 |
| Grade 1-vs-Grade 3 |
9.070200E-02 |
| Grade 1-vs-Grade 4 |
2.883400E-01 |
| Grade 2-vs-Grade 3 |
4.022200E-03 |
| Grade 2-vs-Grade 4 |
3.190600E-01 |
| Grade 3-vs-Grade 4 |
1.727370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.36309901938625E-11 |
| Normal-vs-ccB subtype |
1.691800E-02 |
| ccA subtype-vs-ccB subtype |
7.82070000000523E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.59089999999851E-05 |
| Normal-vs-N1 |
1.158760E-01 |
| N0-vs-N1 |
4.701600E-01 |
|
|
